| pubmed-article:19702845 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19702845 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:19702845 | lifeskim:mentions | umls-concept:C0205474 | lld:lifeskim |
| pubmed-article:19702845 | lifeskim:mentions | umls-concept:C0079488 | lld:lifeskim |
| pubmed-article:19702845 | lifeskim:mentions | umls-concept:C0599779 | lld:lifeskim |
| pubmed-article:19702845 | lifeskim:mentions | umls-concept:C0024623 | lld:lifeskim |
| pubmed-article:19702845 | lifeskim:mentions | umls-concept:C0441471 | lld:lifeskim |
| pubmed-article:19702845 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:19702845 | lifeskim:mentions | umls-concept:C1521991 | lld:lifeskim |
| pubmed-article:19702845 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
| pubmed-article:19702845 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:19702845 | pubmed:dateCreated | 2009-8-25 | lld:pubmed |
| pubmed-article:19702845 | pubmed:abstractText | Gastric cancer remains one of the most common cancers worldwide. A strong association exists between Helicobacter pylori infection and the risk of developing noncardia gastric cancer. H. pylori eradication by antibiotic treatment is regarded as a primary chemoprevention strategy to reduce gastric cancer incidence. | lld:pubmed |
| pubmed-article:19702845 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19702845 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19702845 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19702845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19702845 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19702845 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:19702845 | pubmed:issn | 1523-5378 | lld:pubmed |
| pubmed-article:19702845 | pubmed:author | pubmed-author:KabirShahjaha... | lld:pubmed |
| pubmed-article:19702845 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19702845 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:19702845 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19702845 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19702845 | pubmed:pagination | 159-71 | lld:pubmed |
| pubmed-article:19702845 | pubmed:meshHeading | pubmed-meshheading:19702845... | lld:pubmed |
| pubmed-article:19702845 | pubmed:meshHeading | pubmed-meshheading:19702845... | lld:pubmed |
| pubmed-article:19702845 | pubmed:meshHeading | pubmed-meshheading:19702845... | lld:pubmed |
| pubmed-article:19702845 | pubmed:meshHeading | pubmed-meshheading:19702845... | lld:pubmed |
| pubmed-article:19702845 | pubmed:meshHeading | pubmed-meshheading:19702845... | lld:pubmed |
| pubmed-article:19702845 | pubmed:meshHeading | pubmed-meshheading:19702845... | lld:pubmed |
| pubmed-article:19702845 | pubmed:meshHeading | pubmed-meshheading:19702845... | lld:pubmed |
| pubmed-article:19702845 | pubmed:meshHeading | pubmed-meshheading:19702845... | lld:pubmed |
| pubmed-article:19702845 | pubmed:meshHeading | pubmed-meshheading:19702845... | lld:pubmed |
| pubmed-article:19702845 | pubmed:meshHeading | pubmed-meshheading:19702845... | lld:pubmed |
| pubmed-article:19702845 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19702845 | pubmed:articleTitle | Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: underlying biochemical and molecular events. | lld:pubmed |
| pubmed-article:19702845 | pubmed:affiliation | Academic Research and Information Management, Uppsala, Sweden. acarim99@yahoo.co.uk | lld:pubmed |
| pubmed-article:19702845 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19702845 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19702845 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19702845 | lld:pubmed |
